![Ali Hariri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ali Hariri
Technik-/Wissenschafts-/F&E-Leiter bei
ELOXX PHARMACEUTICALS, INC.
Profil
Ali Hariri is currently the Chief Medical Officer at Eloxx Pharmaceuticals, Inc. Prior to this, he worked as the Senior Head-Global Project at Genzyme Corp.
from 2016 to 2021.
He completed his undergraduate degree at The California State University and his doctorate at UC San Diego School of Medicine.
Aktive Positionen von Ali Hariri
| Unternehmen | Position | Beginn |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.09.2021 |
Ehemalige bekannte Positionen von Ali Hariri
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.08.2021 |
Ausbildung von Ali Hariri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UC San Diego School of Medicine
 UC San Diego School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
